Skip to main content

Headlines

Syndax Pharma Prices Public Offering Of 10.8 Mln Shares At $18.50/Shr
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Fraud in a bottle: How Big Pharma takes on criminals who make millions off counterfeit drugs
posted:
by: CNBC Business
#channels:: #All, #News, #Business, #CNBCBusiness, #CNBC, #Stocks, #Markets
Syndax Pharma Reveals Positive Data From Phase 1 Revumenib Combination Trials In Acute Leukemias
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Basilea Pharma: Astellas Pharma Gets FDA Approval For Cresemba's Expanded Use In Kids With IA, IM
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Medtronic And Cosmo Pharma's Expanded Partnership To Incorporate AI Into Endoscopic Care
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
US Supreme Court set to review Purdue Pharma bankruptcy settlement
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
1 Pharma Stock to Buy on Strong Vaccine Growth Potential
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Astellas Pharma To Buy Propella Therapeutics For About $175 Mln
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
IP Group: Autifony Signs Up To $770 Mln Worth Global Licencing Deal With Jazz Pharma
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
UroGen Pharma (FRA:UR8) Price Target Increased by 29.89% to 36.83
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Lipella Pharma: FDA Grants Orphan Designation For LP-310 To Treat Oral Graft-versus-Host Disease
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Pharma ETFs in Focus Post Q3 Earnings
posted:
by: Nasdaq Technology
#channels:: #All, #Business, #Nasdaq, #Technology, #NasdaqTechnology, #Stocks
Teva Pharma Boosts FY23 Revenue Outlook - Update
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Lumos Pharma (LUMO) Reports Q3 Loss, Lags Revenue Estimates
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks